SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its MassHunter BioConfirm 12.0 software, which now supports data generated by Agilent ...

Life sciences company Agilent Technologies ($A) recently announced it would build a new U.S. plant that will more than double Agilent’s commercial manufacturing ...

Agilent Technologies has picked northern Colorado to build an API plant and add up to 200 jobs. The life sciences company said this week that it has bought 20 acres in Weld County, CO, and will build ...

Agilent Technologies Inc. plans to start manufacturing at its new Frederick plant in the second quarter of this year. The plant will make oligonucleotide active pharmaceutical ingredients that ...

Agilent Technologies plans to spend $150 million to double capacity for oligonucleotides—short DNA and RNA molecules used to create nucleic acid–based therapies—at its facility in Frederick, Colorado.

Synthetic oligonucleotides have emerged as promising therapeutic agents for the treatment of a variety of diseases, including viral infections and cancer. Researchers are looking at several classes of ...

Agilent Technologies has opened a 12,500 m 2 oligonucleotide production plant in Frederick, Colorado, to meet growing demand for the RNA and DNA molecules that biotech firms are developing as ...

"Key players in the oligonucleotide CDMO market include Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), Agilent Technologies, Inc. (US), Kaneka Eurogentec S.A. (Belgium), Ajinomoto Co., Inc. ...

Oligonucleotide therapeutics make up a small but rapidly growing segment of the overall global drug pipeline, with 245 programs currently in development today. While only one approved oligo ...

SANTA CLARA, Calif., September 29, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ...

"Prominent players in the oligonucleotide CDMO market are Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), Agilent Technologies, Inc. (US), Kaneka Eurogentec ...

Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a significant patent for comparative genomic hybridization methods. CGH methods help researchers study genetics and cancer in ...